Difelikefalin Price Comparison

View full research →
Moderate-to-severe CKD-associated pruritus in hemodialysis patientsSafety Rating 8/10

Price Comparison

Compare vendors

No vendor pricing available for this peptide yet.

Research details

Difelikefalin — research data

Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.

Research dose range0.5 mcg/kg IV at end of each dialysis session
AdministrationIntravenous
Safety8/10 · FDA-approved (Korsuva)
NCAA D1Not listed

Overview

About Difelikefalin

Mechanism of action

Selective peripherally restricted kappa opioid receptor agonist; reduces itch signaling

Safety profile

Dizziness, nausea, somnolence, falls · Approved for CKD pruritus; no classic opioid abuse potential; dizziness, diarrhea

📈

Price tracking starts now.

Set an alert to get notified when this peptide drops.

Related pages

More on Difelikefalin

Failed to fetch